Proshares Trust ZBIO
ZBIO
$28.08 -0.10 (-0.35%)
At close: Oct 21, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) Asset Utilization Ratio (2024 - 2026)

Updated

Zenas BioPharma's (ZBIO) Asset Utilization Ratio was 0.00 for Q2 2026, down 97.1% from 0.05 a year earlier.

Analysis

Zenas BioPharma (ZBIO) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at Zenas BioPharma was 0.03, up 16.3% from FY2024.

  • By year, Asset Utilization Ratio came in at 0.02 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Zenas BioPharma 1.77 Bn 1.09 Bn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2025 0.03
Sep 30, 2025 0.05
Jun 30, 2025 0.05
Mar 31, 2025 0.04
Dec 31, 2024 0.01
API Access

Zenas BioPharma Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ZBIO&period=max&api_key=YOUR_API_KEY